OPEN END TURBO LONG - ABBOTT LABORATORIES Stock

Certificat

DE000MC8EYS8

Real-time Bid/Ask 07:31:13 2024-05-24 am EDT
1.21 EUR / 1.28 EUR +2.05% Intraday chart for OPEN END TURBO LONG - ABBOTT LABORATORIES
Current month-15.86%
1 month-23.75%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-24 1.2 -1.64%
24-05-23 1.22 -5.43%
24-05-22 1.29 +16.22%
24-05-21 1.11 -4.31%
24-05-20 1.16 -4.13%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 04:15 am EDT

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN MC8EYS
ISINDE000MC8EYS8
Date issued 2020-04-08
Strike 91.25 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.63
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 5.52
Lowest since issue 0.3
Spread 0.07
Spread %5.38%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.2 USD
Average target price
125.7 USD
Spread / Average Target
+20.59%
Consensus